Hyperfine, Inc. reported second quarter 2026 financial results on August 6, 2026. Revenue increased 44.8% to $3.9 million from $2.7 million in the prior year period, driven by a 50% increase in commercial system sales to 12 units. Gross profit rose to $2.0 million with a gross margin of 50.7%. The company reported a net loss of $9.3 million, or $0.09 per share, compared to a $9.2 million loss in the prior year. Cash and cash equivalents stood at $43.5 million as of June 30, 2026. Management reaffirmed full-year 2026 revenue guidance of approximately $20 to $22 million. The company operates in the health technology industry, developing portable magnetic resonance brain imaging systems.